Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 3 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Holders of 5% or more of BOLT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bolt Biotherapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Coastlands Capital LP | 13G | 17.50%412.4K shares | New | Nov 6, 20261 filing | Nov 6, 2026 | SEC |
| Tang Capital Management LLC | 13G/A | 9.90%3.81M shares | – | May 15, 20251 filing | May 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
33 Schedule 13D and 13G filings on Bolt Biotherapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 20263:35 PM ET | Renaissance Technologies LLCand 1 other | 13G/A | 4.82%92.9K shares | −0.31 ppfrom 5.13%Below 5% | Sep 30, 2026 | SEC |
| Nov 6, 20266:05 PM ET | Coastlands Capital LPand 4 others | 13G | 17.50%412.4K shares | New | Oct 30, 2026 | SEC |
| Aug 13, 20264:20 PM ET | Renaissance Technologies LLCand 1 other | 13G | 5.13%98.6K shares | New | Jun 24, 2026 | SEC |
| Feb 26, 20267:22 PM ET | Pivotal bioVenture Partners Fund I, L.P.and 10 others | 13D/A | 4.60%87.5K shares | −2.10 ppfrom 6.70%Below 5% | Feb 24, 2026 | SEC |
| Feb 17, 20268:11 PM ET | Pivotal bioVenture Partners Fund I, L.P.and 10 others | 13D/A | 6.70%128.1K shares | – | Feb 5, 2026 | SEC |
| Feb 13, 20266:48 PM ET | Vivo Panda Fund, L.P.and 4 others | 13G/A | 3.80%72.4K shares | –Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20254:17 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 3.50%66.9K shares | 0.00 ppfrom 3.50%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 3.50%66.9K shares | −5.20 ppfrom 8.70%Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 8.70%166.9K shares | – | Jun 30, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 9.90%3.81M shares | – | Mar 31, 2025 | SEC |
| Nov 14, 2024 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Tang Capital Partners LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vivo Capital VIII, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Pivotal bioVenture Partners Fund I, L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 20, 2023 | Tang Capital Partners LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Suvretta Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 4, 2023 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Dec 28, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Sep 30, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Jul 15, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| May 16, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Nov 29, 2021 | Suvretta Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Nov 22, 2021 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Aug 13, 2021 | Pivotal bioVenture Partners Fund I, L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 7, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 19, 2021 | Citadel Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 18, 2021 | Vivo Capital VIII, LLC | 13GOld format | – | New | – | SEC |
| Feb 17, 2021 | Pivotal bioVenture Partners Fund I, L.P. | 13DOld format | – | New | – | SEC |
| Feb 16, 2021 | Sofinnova Venture Partners X, L.P. | 13DOld format | – | New | – | SEC |
| Feb 11, 2021 | Novo Holdings A/S | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Bolt Biotherapeutics, Inc. shares.
No Form 144 notices for Bolt Biotherapeutics, Inc. are on file.